Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, Sudan

African Health Sciences

Volumn 12, Issue 3, 2012, Pages 368-375

  Ibrahim, M E ^a   Bilal, N E ^a   Hamid, M E ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

E. coli; Multi drug resistance; Sudan

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; TETRACYCLINE; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT ESCHERICHIA COLI; NONHUMAN; PREVALENCE; SEX DIFFERENCE; SUDAN; URINE; WOUND;

E. COLI; MULTI-DRUG RESISTANCE; SUDAN;

ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; SUDAN;

EID: 84872439940     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v12i3.19     Document Type: Article

References (30)

1. Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J. Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis 2005; 11:546-553.
2. Drago L, Nicola L, Mattina R, Vecchi, ED. In vitro lselection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations. BMC Microbiol 2010; 10:119.
3. Bartoloni A, Pallecchi L, Benedetti M. et al. Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis 2006; 12:907-913.
4. Magiorakos AP, Srinivasan A, Carey RB. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011 May 7. doi: 10.1111/j.1469-0691.2011.03570.x.
5. Bilal NE and Gedebou M. Clinical and community strains of Klebsiella pneumoniae:multiple and increasing rates of antibiotic resistance in Abha, Saudi Arabia. Br J Biomed Sci 2000; 57:185-191.
6. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States. Antimicrob Agents Chemother 2001; 45:1402-14026.
7. Oteo J, Campos J, Baquero F. Spanish members of the European Antimicrobial Resistance Surveillance System. Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001). J Antimicrob Chemother 2002; 50:945-952.
8. Peralta G, Sánchez MB, Garrido JC. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 2007; 60:855-863.
9. Howard DH, Scott RD 2nd, Packard R, Jones D. The Global Impact of Drug Resistance. Clin Infect Dis 2003; 36(Suppl 1):S4-1
10. Coates A, Hu Y, Bax R, Page C. The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov 2002; 1:895-910.
11. Rahman S, Parvez AK, Islam R, Khan MH. Antibacterial activity of natural spices on multiple drug resistant Escherichia coli isolated from drinking water, Bangladesh. Ann Clin Microbiol Antimicrob 2011; 10:10.
12. Guerra B, Junker E, Schroeter A, Helmuth R, Guth BEC, Beutin L. Phenotypic and genotypic characterization of antimicrobial resistance in Escherichia coli O111 isolates. J Antimicrob Chemother 2006; 57:1210-1214.
13. Boyd LB, Atmar R, Randall GL, Hamill, RJ, Steffen D, Zechiedrich L. Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as function of culture site, age, sex, and location. BMC Infect Dis 2008; 8:4.
14. Kibret M, Abera B. Antimicrobial susceptibility patterns of E. coli from clinical sources in northeast Ethiopia Afr Health Sci 2011; 11(S1): S40-S45
15. Salem MM, Muharram M, Alhosiny IM. Distribution of Classes 1 and 2 Integrons among Multi Drug Resistant E. coli Isolated from Hospitalized Patients with Urinary Tract Infection in Cairo, Egypt. Australian Journal of Basic and Applied Sciences 2010; 4:398-407.
16. Ngwai YB, Akpotu MO, Obidake RE, Sounyo AA, Onanuga A, Origbo SO. Antimicrobial susceptibility of Escherichia coli and other coliforms isolated from urine of asymptomatic students in Bayelsa State, Nigeria. African Journal of Microbiology Research 2010; 5:184-191.
17. Bilal NE, Gedebou M, Al-Mohayia MH. Gramnegative bacilli from hospital and non-hospital personnel: pharyngeal carriage, multi-drug resistance and extended-spectrum â lactamase in Abha, Saudi Arabia. Biomedical Research 2001; 12: 251-258.
18. Kader AA, Kumar AK. Prevalence of extendedspectrum â-lactamase among multidrug resistant Gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med J. 2004; 25: 570-574.
19. Ahmed AA, Osman H, Mansour AM. et al. Antimicrobial agents' resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan. Am J Trop Med Hyg 2000; 63:259-263.
20. Hamdan HZ, Ziad AHZ, Ali SK, Adam I. Epidemiology of urinary tract infections and antibiotics sensitivity among pregnant women at Khartoum North Hospital. Ann Clin Microbiol Antimicrob 2011; 10:2.
21. Thomson Jr RB, Miller JM. Specimen collection, transport, and processing: bacteriology. In: Manual of Clinical Microbiology. 8th edition, edited by Murray PR, Baron EJ, Pfaller MA, Tenover, FC and Yolken RH., Washington, DC: American Society for Microbiology 2003; 286-330.
22. Farmer JJ 3rd. Enterobacteriaceae: Introduction and Identification. In: Manual of Clinical Microbiology. 8th edition, edited by Murray PR, Baron EJ, Pfaller MA, Tenover, FC and Yolken RH., Washington, DC: American Society for Microbiology 2003; 636-653.
23. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; twenty first Informational supplement. CLSI document M100-S21, Wayne, Pa: Clinical and Laboratory Standards Institute, 2011; 31(1).
24. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer betalactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10:867-878.
25. Sahuquillo-Arce JM, Selva M, Perpin ̃a ́n H. et al. Antimicrobial Resistance in More than 100,000 Escherichi coli Isolates According to Culture Site and Patient Age, Gender, and Location. Antimicrob Agents Chemother 2011; 55:1222-1228.
26. Lee G, Cho YH, Shim BS, Lee SD. Risk Factors for Antimicrobial Resistance among the Escherichia coli Strains Isolated from Korean Patients with Acute Uncomplicated Cystitis: A Prospective and Nationwide Study. J Korean Med Sci 2010; 25:1205-1209.
27. Chenia, HY, Pillay B, Pillay D. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens. J Antimicrob Chemother 2006; 58:1274-1278.
28. Namboodiri SS, Opintan JA, Lijek RS, Newman MJ, Okeke IN. Quinolone resistance in Escherichia coli from Accra, Ghana. BMC Microbiol 2011; 11:44.
29. Gupta A, Dwivedi M, Mahdi AA, NaganaGowda GA, Khetrapal CL, Bhandari M. Inhibition of adherence of multi-drug resistant E. coli by proanthocyanidin. Urol Res 2012; 402:143-150.
30. Howell AB, Botto H, Combescure C, et al. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010; 10:94.